"

About

 Coherent Communications is a strategic healthcare communications consultancy.

 We establish, build and communicate the value of healthcare brands from early phase to post-launch. 

We work with pharmaceutical, medical device and biotechnology companies to develop bespoke solutions to challenges faced by products in pre-clinical to post-launch phases of development, across a range of therapy areas and indications, including rare diseases.

In particular we have experience of working with recombinant products, immunotherapy and gene therapy. 

Leadership

Neil McCallum-Deighton PhD

Neil has over 28 years’ experience of the planning and delivery of communications programmes for products in global, European and UK markets.

Neil offers a combination of strategic ability, clinical knowledge and commercial understanding and has worked at a senior level in medical communications, advertising and PR.

What we do

From consultancy to programme delivery

Knowledge and insight

Currently many of the products that we work with are in the areas of recombinant technology, immunotherapy and gene therapy, but we have extensive experience working with all types of pharmaceutical products.

We have worked in most major therapy areas and in particular have expertise in those listed on the right.

If you would like more detail on specific brand or indication experience, or to discuss a potential project, please do contact us.

How we work

Coherent Communications does not operate a standard agency structure. We do things a little differently …

We do not have fixed teams or maintain a permanent office space. Instead we build bespoke teams around each project, made up of highly experienced independent writers, creatives, designers, digital specialists and project managers.

This ensures that we apply the right expertise to suit each client’s needs and deliver the best work possible – from single projects through to complex communications programmes.

It also means that clients’ budgets are focused on delivery … not on overheads.